Filing Details

Accession Number:
0001607062-18-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-22 13:28:21
Reporting Period:
2017-11-13
Accepted Time:
2018-03-22 13:28:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460602 Orgenesis Inc. ORGS Pharmaceutical Preparations (2834) 980583166
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726655 Bruxelles De Libre Universite Avenue F, Roosevelt, 50
Brussels C9 1050
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-13 204,396 $1.83 817,584 No 4 S Direct
Common Stock Disposition 2017-11-15 204,396 $1.83 613,188 No 4 S Direct
Common Stock Disposition 2017-11-17 204,396 $1.83 408,792 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reflects 12 for 1 reversed stock split effective November 16, 2017.
  2. The shares were sold for approximate aggregate purchase price of $373,554.